Democrats may be closer than ever to passing sweeping drug pricing reforms, but Sen. Ron Wyden says there’s more to do.
During a STAT event Wednesday, the Oregon Democrat, who chairs the powerful Senate Finance Committee, outlined a number of additional policies he wants to turn to after the Senate passes the reforms currently up for consideration. That package would deliver on Democrats’ promise to allow Medicare to negotiate over the price of drugs, and would penalize drug makers for hiking their prices faster than inflation.
“It certainly … is a strong start,” Wyden said. “There’s plenty more to do.”